"develop"

#13296471

9 February 2026

A view of an apartment building complex is in a developed urban area of Munich, Bavaria, Germany, on February 3, 2026. Munich remains the most expensive city in Germany for renters. There is an extreme imbalance between high demand and limited supply.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13296472

9 February 2026

A view of an apartment building is in a developed urban area of Munich, Bavaria, Germany, on February 3, 2026. Munich remains the most expensive city in Germany for renters. There is an extreme imbalance between high demand and limited supply.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13296474

9 February 2026

A view of an apartment building is in a developed urban area of Munich, Bavaria, Germany, on February 3, 2026. Munich remains the most expensive city in Germany for renters. There is an extreme imbalance between high demand and limited supply.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13296475

9 February 2026

A view of an apartment building is in a developed urban area of Munich, Bavaria, Germany, on February 3, 2026. Munich remains the most expensive city in Germany for renters. There is an extreme imbalance between high demand and limited supply.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13296476

9 February 2026

A view of an apartment building is in a developed urban area of Munich, Bavaria, Germany, on February 3, 2026. Munich remains the most expensive city in Germany for renters. There is an extreme imbalance between high demand and limited supply.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295607

9 February 2026

The AbbVie logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295608

9 February 2026

The Amgen logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295609

9 February 2026

The AstraZeneca logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295610

9 February 2026

The Bavarian Nordic logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295611

9 February 2026

The BioNTech logo appears on a laptop computer screen in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295612

9 February 2026

The Bristol Myers Squibb logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295613

9 February 2026

The CSL logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295614

9 February 2026

The Dynavax logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295615

9 February 2026

The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295616

9 February 2026

The Emergent logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#13295617

9 February 2026

The Novavax logo appears on a laptop computer screen in this photo illustration in Athens, Greece, on February 9, 2026. Vaccine manufacturers continue to play a central role in global public health, investing in research, development, and distribution of new immunization products. As health challenges evolve worldwide, the industry faces growing demands for innovation, supply chain resilience, and equitable access to vaccines. (Photo Illustration by Nikolas Kokovlis/NurPhoto)

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.